跳至主導覽 跳至搜尋 跳過主要內容

Rituximab-induced hepatitis C virus reactivation in rheumatoid arthritis

  • Ko Ming Lin
  • , Jing Chi Lin
  • , Wen Yi Tseng
  • , Tien Tsai Cheng*
  • *此作品的通信作者
  • Chang Gung Memorial Hospital
  • Chang Gung University

研究成果: 期刊稿件文章同行評審

28 引文 斯高帕斯(Scopus)

摘要

The B-cell depletion agent rituximab (RTX) is used in lymphoma and rheumatoid arthritis (RA), and there have been several case reports of an RTX-induced reactivation of hepatitis C virus in patients with lymphoma. However, there have been no papers detailing hepatitis C virus reactivation after RTX therapy in a patient with RA. Here we report a case of RTX-induced hepatitis C virus reactivation in a patient with RA. Physicians should be aware that a close follow-up of liver function and viral load is mandatory after RTX therapy in patients with RA and concomitant hepatitis C.

原文英語
頁(從 - 到)65-67
頁數3
期刊Journal of Microbiology, Immunology and Infection
46
發行號1
DOIs
出版狀態已出版 - 02 2013
對外發佈

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Rituximab-induced hepatitis C virus reactivation in rheumatoid arthritis」主題。共同形成了獨特的指紋。

引用此